SCHEMBL17004390

SCHEMBL17004390

CC12CC[C@H](C=C1c1ccccc1C=C1CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)cc3)CC1)C2(C)C

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 14/20 0.53
▸ BCL2 P10415 12/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2389444 1.00 BCL2L1 (0.53) BCL2L1BCL2
SCHEMBL2389447 1.00 BCL2L1 (0.53) BCL2L1BCL2
SCHEMBL2385278 0.87 BCL2 (0.59) BCL2
SCHEMBL2384588 0.87 BCL2 (0.59) BCL2
SCHEMBL2386142 0.81 BCL2 (0.58) BCL2
SCHEMBL2388665 0.81 BCL2 (0.50) BCL2L1BCL2
SCHEMBL11973830 0.80 BCL2L1 (0.48) BCL2L1BCL2
SCHEMBL11973825 0.80 BCL2L1 (0.48) BCL2L1BCL2
SCHEMBL2384577 0.80 BCL2 (0.54) BCL2L1BCL2
SCHEMBL17004423 0.79 BCL2 (0.59) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2550258-B1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE INC (US) 2015-08-19 — — EP claimed
Send feedback